Your browser doesn't support javascript.
loading
Precise Cancer Anti-acid Therapy Monitoring Using pH-Sensitive MnO2@BSA Nanoparticles by Magnetic Resonance Imaging.
A, Rong; Yao, Yuzhu; Guo, Xiaolu; Jiang, Weiqi; Jiang, Meng; Yang, Jie; Li, Yingbo; Atinuke, Olagbaju Oluwatosin; Hu, Xuesong; Li, Yuanyuan; Wang, Xiance; Yang, Lili; Yang, Xiangliang; Wang, Kai; Hu, Jun; Sun, Xilin.
Afiliação
  • A R; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Yao Y; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
  • Guo X; National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
  • Jiang W; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Jiang M; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Yang J; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
  • Li Y; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Atinuke OO; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
  • Hu X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Li Y; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
  • Wang X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Yang L; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
  • Yang X; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Wang K; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
  • Hu J; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, Harbin 150028, China.
  • Sun X; Department of Nuclear Medicine, The Fourth Hospital of Harbin Medical University, Harbin 150028, China.
ACS Appl Mater Interfaces ; 13(16): 18604-18618, 2021 Apr 28.
Article em En | MEDLINE | ID: mdl-33856200
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óxidos / Soroalbumina Bovina / Imageamento por Ressonância Magnética / Compostos de Manganês / Nanopartículas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: ACS Appl Mater Interfaces Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óxidos / Soroalbumina Bovina / Imageamento por Ressonância Magnética / Compostos de Manganês / Nanopartículas / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: ACS Appl Mater Interfaces Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China